3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
9
Gynecologic
2
Gastrointestinal
2
CNS
2
Breast
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Dermatologic
1
Conditions
Melanoma
68
Skin Neoplasms
15
Neoplasm Metastasis
14
Lymphoma, T-Cell, Cutaneous
9
Carcinoma, Renal Cell
8
Carcinoma, Non-Small-Cell Lung
8
Breast Neoplasms
8
Neoplasms
7
Lymphoma
7
Ovarian Neoplasms
6
Mycosis Fungoides
6
Kidney Neoplasms
6
Colorectal Neoplasms
6
Carcinoma, Merkel Cell
6
Uveal Melanoma
5
Uterine Cervical Neoplasms
5
Sezary Syndrome
5
Multiple Myeloma
5
Esophageal Neoplasms
5
Carcinoma, Hepatocellular
5
Stomach Neoplasms
4
Sarcoma, Synovial
4
Pancreatic Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Lymphoma, Non-Hodgkin
3
Interventions
pembrolizumab
10
Nivolumab
5
Gemcitabine
4
durvalumab
3
Specimen Handling
3
Sirolimus
3
Magnetic Resonance Spectroscopy
3
Docetaxel
3
Cryosurgery
3
Cisplatin
3
Blood Specimen Collection
3
tremelimumab
2
temsirolimus
2
pertuzumab
2
pegilodecakin
2
enzalutamide
2
cabozantinib
2
alvocidib
2
Vorinostat
2
Trastuzumab
2
Ritonavir
2
Radiotherapy
2
Radiosurgery
2
Psychiatric Rehabilitation
2
Paclitaxel
2
Oxaliplatin
2
Interleukin-2
2
Cyclophosphamide
2
Carboplatin
2
Biopsy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
fludarabine
×
Dermatologic
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled